College Park, MD, United States of America

Varnika Roy

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: University System of Maryland. Active years: 2015.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Varnika Roy: Innovator in Quorum Sensing Inhibition

Introduction

Varnika Roy is a prominent inventor based in College Park, MD (US). She has made significant contributions to the field of microbiology, particularly in the area of quorum sensing inhibition. Her innovative work has the potential to impact the treatment of bacterial infections and biofilm reduction.

Latest Patents

Varnika Roy holds a patent for "Phosphorylated and branched dihydroxy-pentane-dione (DPD) analogs as quorum sensing inhibitors in bacteria." This patent provides compositions and methods for modulating quorum sensing in microbes. The compounds she developed are AI-2 analogs, which have structures similar to 4,5-dihydroxy-2,3-pentanedione. These compounds can act as agonists or antagonists of quorum sensing, making them useful for modulating bacterial behavior. The applications of her work include methods for prophylaxis or therapy of bacterial infections and for the reduction of biofilms.

Career Highlights

Varnika Roy is affiliated with the University System of Maryland, where she continues her research and development in microbiology. Her work has garnered attention for its innovative approach to addressing bacterial communication and infection control.

Collaborations

Varnika collaborates with esteemed colleagues, including Herman O Sintim and William E Bentley, who contribute to her research endeavors.

Conclusion

Varnika Roy's contributions to the field of quorum sensing inhibition highlight her innovative spirit and dedication to advancing microbiological research. Her patented work has the potential to lead to significant advancements in the treatment of bacterial infections and biofilm management.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…